I'm LongbridgeAI, I can summarize articles.Insulet Corp. (PODD) shares rose 1.19% to $142.85 on Monday, marking its third consecutive day of gains despite a broader market decline. However, the stock underperformed compared to key competitors like Eli Lilly, DexCom, and Johnson & Johnson, which all posted stronger daily increases. Insulet remains significantly below its 52-week high of $354.88.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Insulet Corp. (PODD) advanced 1.19% to $142.85 Monday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.06% to 7,753.11 and Dow Jones Industrial Average falling 0.11% to 53,975.98.
This was the stock's third consecutive day of gains.
Insulet Corp. closed 59.75% below its 52-week high of $354.88, which the company achieved on November 20th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Eli Lilly & Co. (LLY) rose 3.90% to $1,231.94, DexCom Inc. (DXCM) rose 3.42% to $87.65, and Johnson & Johnson (JNJ) rose 0.99% to $261.81.
Data source: Dow Jones Market Data, FactSet. Data compiled August 10, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
08-10-26 1719ET